BioNTech SE ADR buy TraderAS
Start price
29.08.21
/
50%
€306.90
Target price
28.02.22
€505.00
Performance (%)
-57.66%
End price
28.02.22
€129.95
Summary
This prediction ended on 28.02.22 with a price of €129.95. Massive losses of -57.66% were the result for the BUY prediction by TraderAS. TraderAS has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioNTech SE ADR | 7.896% | 7.896% | 243.124% |
| iShares Core DAX® | -0.683% | 1.890% | 15.367% |
| iShares Nasdaq 100 | 0.335% | 4.631% | 29.818% |
| iShares Nikkei 225® | -1.486% | -2.361% | 7.668% |
| iShares S&P 500 | -0.523% | 2.324% | 25.460% |
According to TraderAS what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
High dividend yield expected
positive Cash Flow expected
Top Rating
High Investments for future growth
Very valuable balance sheet
Small challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Small Risks for its business
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Deficits in Management
Very bad culture
Sustainability is little important
Mainly gamblers invest here
Comments by TraderAS for this prediction
In the thread Biontech SE diskutieren
Buy mit Kursziel 505,0
In the thread Trading Biontech SE
Die von TraderAS gewählte maximale Laufzeit wurde überschritten